Efficacy and Safety of Glecaprevir/Pibrentasvir in HCV Patients With Previous Direct-Acting Antiviral Therapy Failures: A Meta-Analysis

Efficacy and Safety of Glecaprevir/Pibrentasvir in HCV Patients With Previous Direct-Acting Antiviral Therapy Failures: A Meta-Analysis

Background: Since a greater number of hepatitis C virus (HCV) patients have access to direct-acting antiviral (DAA) based therapies, the number of patients not properly responding to prior DAA regimens is increasing. The objective of this comprehensive analysis was to assess the efficacy and safety...

Full description

Bibliographic Details
Main Authors: Chao Shen, Haozhi Fan, Zhijun Ge, Weihua Cai, Jianguo Shao, Chen Dong, Hong Xue, Zuqiang Fu, Jun Li, Yun Zhang, Ming Yue
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-12-01
Series:Frontiers in Medicine
Subjects:
pibrentasvir
retreatment
DAAs therapy failures
meta-analysis
glecaprevir
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2020.592472/full

Similar Items

Similar Items